Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Scientists at National Cancer Institute detail research in cancer vaccines
June 3rd, 2008
Researchers detail in 'Paradigm shifts in cancer vaccine therapy,' new data in cancer. According to recent research from the United States, "Cancer vaccines constitute a unique therapeutic modality in that they initiate a dynamic process involving the host's immune response. Consequently, (a) repeated doses (vaccinations) over months may be required before patient clinical benefit is observed and (b) there most likely will be a 'dynamic balance' between the induction and maintenance of host immune response elements to the vaccinations vs. host/tumor factors that have the potential to diminish those responses." "Thus 'patient response' in the form of disease...
Source: Cancer Weekly (2008-06-03)
|
